Literature DB >> 22469082

Niclosamide: comprehensive profile.

Badraddin M H Al-Hadiya1.   

Abstract

Entities:  

Year:  2006        PMID： 22469082     DOI： 10.1016/S0099-5428(05)32002-8

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN： 1871-5125


× No keyword cloud information.
  29 in total

1.  SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Authors:  Yonghe Li; Patsy G Oliver; Wenyan Lu; Vibha Pathak; Sivaram Sridharan; Corinne E Augelli-Szafran; Donald J Buchsbaum; Mark J Suto
Journal:  Cancer Lett       Date:  2016-12-30       Impact factor: 8.679

Review 2.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

3.  Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, a Repurposed Drug with Poor Bioavailability.

Authors:  Xiaoyu Fan; Hongmin Li; Xinxin Ding; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2019-04-30       Impact factor: 3.922

4.  Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; James A MacLean; Kanako Hayashi
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

5.  Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen.

Authors:  Miao Xu; Emily M Lee; Zhexing Wen; Yichen Cheng; Wei-Kai Huang; Xuyu Qian; Julia Tcw; Jennifer Kouznetsova; Sarah C Ogden; Christy Hammack; Fadi Jacob; Ha Nam Nguyen; Misha Itkin; Catherine Hanna; Paul Shinn; Chase Allen; Samuel G Michael; Anton Simeonov; Wenwei Huang; Kimberly M Christian; Alison Goate; Kristen J Brennand; Ruili Huang; Menghang Xia; Guo-Li Ming; Wei Zheng; Hongjun Song; Hengli Tang
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

6.  Synthesis and biological evaluation of novel 5-chloro-N-(4-sulfamoylbenzyl) salicylamide derivatives as tubulin polymerization inhibitors.

Authors:  Alaaeldin M F Galal; Maha M Soltan; Esam R Ahmed; Atef G Hanna
Journal:  Medchemcomm       Date:  2018-07-26       Impact factor: 3.597

7.  Defined Host-Guest Chemistry on Nanocarbon for Sustained Inhibition of Cancer.

Authors:  Fatemeh Ostadhossein; Santosh K Misra; Prabuddha Mukherjee; Alireza Ostadhossein; Enrique Daza; Saumya Tiwari; Shachi Mittal; Mark C Gryka; Rohit Bhargava; Dipanjan Pan
Journal:  Small       Date:  2016-08-22       Impact factor: 13.281

Review 8.  [Cancer stem cells as the therapeutic target of tomorrow].

Authors:  Jiří Hatina
Journal:  Wien Med Wochenschr       Date:  2016-03-04

Review 9.  Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.

Authors:  Yonghe Li; Pui-Kai Li; Michael J Roberts; Rebecca C Arend; Rajeev S Samant; Donald J Buchsbaum
Journal:  Cancer Lett       Date:  2014-04-13       Impact factor: 8.679

10.  Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.

Authors:  Junjun Liu; Xiaosong Chen; Toby Ward; Mark Pegram; Kunwei Shen
Journal:  Tumour Biol       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.